Correlation Between Monopar Therapeutics and AC Immune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and AC Immune, you can compare the effects of market volatilities on Monopar Therapeutics and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and AC Immune.

Diversification Opportunities for Monopar Therapeutics and AC Immune

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monopar and ACIU is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and AC Immune go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and AC Immune

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 5.22 times more return on investment than AC Immune. However, Monopar Therapeutics is 5.22 times more volatile than AC Immune. It trades about 0.05 of its potential returns per unit of risk. AC Immune is currently generating about 0.04 per unit of risk. If you would invest  1,340  in Monopar Therapeutics on August 26, 2024 and sell it today you would earn a total of  670.00  from holding Monopar Therapeutics or generate 50.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  AC Immune

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
AC Immune 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AC Immune are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak forward indicators, AC Immune may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Monopar Therapeutics and AC Immune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and AC Immune

The main advantage of trading using opposite Monopar Therapeutics and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.
The idea behind Monopar Therapeutics and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA